Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
ReCode Therapeutics is a genetic medicines company that specializes in mRNA and gene correction therapeutics.
Empatica is an affective computing company focused on human data analytics.
Epic Bio's strength is a relentless focus on ushering in a new era of gene regulation.
Inozyme is a biopharmaceutical company developing therapeutics for rare diseases, with a focus on bone health.
Q32 Bio is a biotechnology company that develops treatments for patients with severe autoimmune and inflammatory diseases.
Bionyra Pharma is a clinical-stage biopharmaceutical startup developing next-generation biologics for severe immune-mediated inflammation.
Nura Bio is a biotechnology company that develops neuroprotective therapies for neurological disorders.
Veralox Therapeutics develops small molecule therapeutics that treat the underlying pathologies of thrombosis and type one diabetes.
Memento Medicines is a biotech developing bispecific antibody therapies for eye diseases.
The AI Platform for Pharma Commercialization
Eligobiotics provides a new approach to explore, understand, and control bacterial ecosystems both in human and animals.
Click Therapeutics develops and commercializes software as prescription medical treatments designed to address unmet healthcare needs.
Glycomine is an early-stage biotech working on replacement therapies for rare diseases.
Attovia Therapeutics is a biologics platform specializing in biotherapeutics for immune-mediated diseases.
QurAlis is a biotechnology company that creates precision medicine solutions to cure ALS and FTD.
Curevo is a clinical-stage biotechnology company developing next-generation, non-mRNA vaccines for infectious diseases.
Latigo Biotherapeutics is a clinical-stage biotechnology company that develops novel, non-opioid therapies for chronic pain.
QuantX Biosciences is a biotechnology company that specializes in computational drug discovery and small-molecule therapeutic products.
Avilar Therapeutics is a biopharmaceutical company focusing on extracellular protein degradation.
NextPoint Therapeutics is a clinical-stage biotechnology company that develops therapeutics to treat cancer patients.
Sudo Biosciences is a biopharma company that designs and develops medicines that target the tyrosine kinase 2 (TYK2) pseudokinase domain.
Character Bio is a platform that merges genomics with clinical data and AI technology, focusing on patients affected by AMD.
Granite Bio is a biotechnology business developing novel antibodies to treat inflammatory, autoimmune, and fibrotic disorders.
I2o Therapeutics is a biotech company that develops safe and effective oral formulations of therapies.
Sanofi Ventures has invested in 71 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Sanofi Ventures's top investment sectors include Biotechnology, Health Care, Medical, Therapeutics, Pharmaceutical. The firm invests across 17 different industry categories.
Among tracked funding rounds, Q32 Bio received $200.0M in a Post-IPO Equity round. Sanofi Ventures's total known invested capital is $3.1B.
Sanofi Ventures's average investment size is $57.6M across its portfolio of 71 companies.
Recent Sanofi Ventures portfolio additions include ReCode Therapeutics, Empatica, Epicrispr Biotechnologies, Inozyme, Q32 Bio. These companies were founded in 2020 or later.